Multicenter study to evaluate paxalisib plus gemcitabine for children and young adults with recurrent or progressive AT/RT, where no approved therapies currently exist SYDNEY, Sept....
JAKARTA, Indonesia, April 10, 2025 /PRNewswire/ -- APP Group reaffirms its commitment to environmental responsibility by supporting Thailand's sustainability initiatives, including the country's January...
HSINCHU, April 10, 2025 /PRNewswire/ -- ChipMOS TECHNOLOGIES INC. ("ChipMOS" or the "Company") (Taiwan Stock Exchange: 8150 and Nasdaq: IMOS), an industry leading provider...
KUALA LUMPUR, Malaysia, April 10, 2025 /PRNewswire/ -- Informa Markets announces the launch of Medtec Southeast Asia 2025, the premier medical device design and...
Immerse in a buzzing modern metropolis SHENZHEN, China, April 10, 2025 /PRNewswire/ -- An inspiring city retreat awaits at Four Seasons Hotel Shenzhen, an...